CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma

Published:2012-10-31 Issue:1 Volume:29 Page:21-28
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

AMATYA VISHWA JEET,TAKESHIMA YUKIO,AOE KEISUKE,FUJIMOTO NOBUKAZU,OKAMOTO TOSHIHIRO,YAMADA TAKETO,KISHIMOTO TAKUMI,MORIMOTO CHIKAO,INAI KOUKI

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value and multifaceted roles of tetraspanin CD9 in cancer;Frontiers in Oncology;2023-03-17

2. Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-11-19

3. Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis;Cancer Cell International;2021-09-07

4. CD9, a tetraspanin target for cancer therapy?;Experimental Biology and Medicine;2021-02-18

5. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling;Cell Death & Disease;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP